Kinfo
Recursion Pharmaceuticals, Inc. logo

Recursion Pharmaceuticals, Inc.

RXRXNASDAQHealthcare·US · USD
$3.68
+0.16 (+4.40%)
Live · 2026-06-29

Price

Key statistics

Valuation
Market cap1.87B USD
Enterprise value1.28B USD
Trailing P/E-2.56
Forward P/E-4.01
PEG ratio0.05
Price / sales28.13
Price / book1.82
Profitability
Gross margin-98.22%
Operating margin-1985.55%
Profit margin4.45%
Return on assets-27.66%
Return on equity-57.16%
Income (TTM)
Revenue66.41M USD
Gross profit-428.74M USD
EBITDA-501.23M USD
Net income-559.78M USD
Diluted EPS-$1.16
Rev. growth (YoY)-56.10%
Balance sheet
Total cash654.47M USD
Total debt72.38M USD
Debt / equity7.06
Current ratio5.47
Book value / share$1.93
Cash flow (TTM)
Operating cash flow-320.95M USD
Levered free cash flow-177.80M USD
Shares & price
Shares outstanding530.63M
Float512.98M
Held by institutions68.78%
Beta1.00
50-day MA$3.32
200-day MA$4.12
52-week high$7.18
52-week low$2.77
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-06-041.451.64+13.10%2026-05-06-0.26-0.22+15.38%2026-02-25-0.32-0.21+34.38%2026-02-033.323.33+0.30%2026-01-200.880.89+1.14%
About Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on using automation, artificial intelligence, machine learning, and data science to discover novel medicines. Recursion Pharmaceuticals develops a technology-driven drug discovery platform that combines biology, chemistry, engineering, and computational tools to identify potential drug candidates, study mechanisms of action, and evaluate safety signals. Its work centers on industrializing the process of discovering therapeutics for serious diseases, with programs that span multiple research areas within the life sciences. The company operates as a biotechnology platform business, supporting both internal drug development and broader scientific applications through its integrated Recursion operating system. Headquartered in Salt Lake City, Utah, and founded in 2013, Recursion Pharmaceuticals plays a distinctive role in the market by merging advanced computing with experimental biology to accelerate modern drug discovery.

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Najat Khan Ph.D.
Employees
600
Headquarters
Salt Lake City, UT, United States

Frequently asked questions about Recursion Pharmaceuticals, Inc.